This article has been corrected | View Correction
ArticlesFull Access
Published Online:16 Dec 2019https://doi.org/10.1176/appi.ajp.2019.19010034
- Cited by
- European Neuropsychopharmacology, Vol. 84
- European Neuropsychopharmacology, Vol. 83
- European Neuropsychopharmacology, Vol. 82
- 19 April 2024 | Journal of Clinical Psychopharmacology, Vol. 163
- 17 March 2024 | Journal of Psychopharmacology, Vol. 38, No. 4
- 5 November 2023 | Neuropsychopharmacology Reports, Vol. 44, No. 1
- 30 January 2024 | Pharmaceuticals, Vol. 17, No. 2
- Schizophrenia Research, Vol. 264
- Schizophrenia Research, Vol. 264
- 23 June 2023 | Schizophrenia Bulletin, Vol. 50, No. 1
- 12 January 2024 | Biomedicines, Vol. 12, No. 1
- Advances in Clinical Medicine, Vol. 14, No. 02
- Current Neuropharmacology, Vol. 21, No. 11
- The Lancet Psychiatry, Vol. 10, No. 11
- 16 October 2023 | Schizophrenia Bulletin, Vol. 3
- 23 September 2023 | Journal of Psychopharmacology, Vol. 37, No. 10
- 17 July 2023 | Psychopharmacology, Vol. 240, No. 9
- 3 August 2023 | Molecular Psychiatry, Vol. 28, No. 8
- 27 August 2023 | Health Science Reports, Vol. 6, No. 8
- European Neuropsychopharmacology, Vol. 72
- Clinical Psychopharmacology and Neuroscience, Vol. 21, No. 2
- Journal of Psychiatric Research, Vol. 161
- 27 March 2023 | Nutrients, Vol. 15, No. 7
- Journal of Clinical Psychopharmacology, Vol. 43, No. 2
- 1 March 2023 | BioMedInformatics, Vol. 3, No. 1
- 20 January 2023 | Brain Sciences, Vol. 13, No. 2
- 20 January 2023 | International Journal of Molecular Sciences, Vol. 24, No. 3
- 14 January 2023 | World Psychiatry, Vol. 22, No. 1
- 7 February 2023 | BMJ Mental Health, Vol. 26, No. 1
- 11 May 2023 | Therapeutic Advances in Psychopharmacology, Vol. 13
- 13 September 2023 | Therapeutic Advances in Psychopharmacology, Vol. 13
- 1 October 2023 | Neuropsychiatric Disease and Treatment, Vol. Volume 19
- 1 January 2023 | Česká a slovenská farmacie, Vol. 72, No. 5
- 14 December 2022 | Frontiers in Psychiatry, Vol. 13
- 11 November 2022 | PharmacoEconomics, Vol. 40, No. 12
- 11 November 2022 | PharmacoEconomics, Vol. 40, No. 12
- Trends in Pharmacological Sciences, Vol. 43, No. 12
- 4 May 2022 | Schizophrenia, Vol. 8, No. 1
- 27 July 2022 | International Journal of Neuropsychopharmacology, Vol. 25, No. 11
- 18 November 2022 | Expert Opinion on Pharmacotherapy, Vol. 23, No. 16
- 5 October 2022 | Psychopharmacology, Vol. 239, No. 11
- Psychiatry Research, Vol. 317
- 17 August 2022 | Frontiers in Psychiatry, Vol. 13
- 23 August 2022 | Mental Health Clinician, Vol. 12, No. 4
- 1 August 2022 | International Journal of Psychiatry in Clinical Practice, Vol. 27
- 6 June 2022 | Psychiatry and Clinical Neurosciences, Vol. 76, No. 8
- 25 February 2022 | Acta Psychiatrica Scandinavica, Vol. 146, No. 1
- 10 May 2022 | Schizophrenia Bulletin, Vol. 48, No. 4
- Journal of Psychiatric Research, Vol. 150
- 19 January 2021 | CNS Spectrums, Vol. 27, No. 3
- 8 February 2022 | Schizophrenia Bulletin, Vol. 48, No. 3
- 11 February 2022 | Journal of Clinical Psychopharmacology, Vol. 42, No. 3
- 22 February 2022 | Acta Psychiatrica Scandinavica, Vol. 145, No. 5
- 1 March 2022 | Acta Psychiatrica Scandinavica, Vol. 145, No. 5
- 7 April 2022 | Frontiers in Psychiatry, Vol. 13
- 6 April 2022 | Frontiers in Psychiatry, Vol. 13
- Neuroscience & Biobehavioral Reviews, Vol. 135
- 12 November 2021 | Psychological Medicine, Vol. 52, No. 4
- 7 January 2022 | Journal of Clinical Psychopharmacology, Vol. 42, No. 2
- Journal of Clinical Psychopharmacology, Vol. 42, No. 2
- 17 January 2022 | European Archives of Psychiatry and Clinical Neuroscience, Vol. 272, No. 1
- JAMA Psychiatry, Vol. 79, No. 1
- NeuroImage: Clinical, Vol. 33
- 30 July 2022 | Therapeutic Advances in Psychopharmacology, Vol. 12
- 1 February 2022 | Neuropsychiatric Disease and Treatment, Vol. Volume 18
- 17 August 2021 | Expert Opinion on Pharmacotherapy, Vol. 22, No. 18
- 2 December 2021
- 13 September 2021 | npj Schizophrenia, Vol. 7, No. 1
- 10 March 2021 | Scientific Reports, Vol. 11, No. 1
- 11 November 2021 | BMC Psychiatry, Vol. 21, No. 1
- 18 May 2021 | Nature Communications, Vol. 12, No. 1
- Neuroscience & Biobehavioral Reviews, Vol. 131
- 12 November 2021 | Frontiers in Molecular Neuroscience, Vol. 14
- JAMA Psychiatry, Vol. 78, No. 11
- 23 September 2021 | Journal of Clinical Psychopharmacology, Vol. 41, No. 6
- International Journal of Electrochemical Science, Vol. 16, No. 10
- 14 July 2021 | Journal of Psychopharmacology, Vol. 35, No. 9
- 22 March 2021 | Schizophrenia Bulletin, Vol. 47, No. 5
- Psychiatry Research, Vol. 302
- 15 July 2021 | Ukrains'kyi Visnyk Psykhonevrolohii, No. Volume 29, issue 2 (107)
- 23 March 2021 | Schizophrenia Bulletin, Vol. 47, No. 4
- European Neuropsychopharmacology, Vol. 47
- Journal of Vascular and Interventional Radiology, Vol. 32, No. 6
- Neuroscience & Biobehavioral Reviews, Vol. 125
- JAMA Psychiatry, Vol. 78, No. 3
- 26 March 2021 | InFo Neurologie + Psychiatrie, Vol. 23, No. 3
- Behavioural Brain Research, Vol. 402
- 18 February 2021 | Frontiers in Psychiatry, Vol. 12
- 6 August 2020 | Schizophrenia Bulletin, Vol. 47, No. 1
- 28 January 2021 | CNS Drugs, Vol. 35, No. 1
- 10 May 2021 | Therapeutic Advances in Psychopharmacology, Vol. 11
- 16 May 2020 | Schizophrenia Bulletin, Vol. 46, No. 6
- 1 January 2020 | Pharmacotherapy in Psychiatry and Neurology, Vol. 36, No. 3
- European Neuropsychopharmacology, Vol. 40
- Lurasidone – pharmacodynamic and pharmacokinetic properties, clinical potential and interaction risk7 September 2020 | Pharmacotherapy in Psychiatry and Neurology, Vol. 36, No. 2
- Targeting Serotonin 5-HT2A Receptors to Better Treat Schizophrenia: Rationale and Current Approaches11 August 2020 | CNS Drugs, Vol. 34, No. 9
- 7 August 2020 | Neuropsychopharmacology Reports, Vol. 40, No. 3
- Bell-shaped dose-response curve of antipsychotic drugs and dopaminergic auto-receptors: a hypothesisClinical Neuropsychopharmacology and Therapeutics, Vol. 11, No. 0
- 30 January 2020 | Psychopharmacology, Vol. 237, No. 5
- 20 April 2020 | Frontiers in Psychiatry, Vol. 11
- Ned H. Kalin,
M.D.
1 April 2020 | American Journal of Psychiatry, Vol. 177, No. 4- Ned H. Kalin,
Metrics
The authors thank Samantha Roberts for her help with the literature search and Maximilian Huhn and Marc Krause for their help in selecting studies.
History
Received 12 January 2019
Revised 26 August 2019
Accepted 30 September 2019
Published online 16 December 2019
Published in print 1 April 2020